Trial intelligence / Profile preview

Singulair + Moderate ICS vs High ICS in Obese Asthma

NCT01016847Phase 4Terminated

Sponsor
Duke University
Start
Jan 2010
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of montelukast in asthma, sponsored by Duke University. Started Jan 2010; status: terminated.

02

Drugs

montelukast
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01016847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01016847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call